Department of Pharmacology Archives
Aug. 7, 2014—An enzyme therapy may prevent skeletal abnormalities associated with the genetic disorder neurofibromatosis type-1, Vanderbilt investigators have discovered.
Jun. 12, 2014—During her 13-year tenure as chair of Vanderbilt University’s Department of Pharmacology, Heidi Hamm, Ph.D., bolstered its international reputation, attracted 18 new faculty members and helped take it in new directions, such as drug discovery.
Mar. 27, 2014—Neuroscientist and biophysicist David Clapham, M.D., Ph.D., known for his studies of ion channels and cell signaling, will deliver the next Flexner Discovery Lecture on Thursday, April 3, in 208 Light Hall.